Halda Therapeutics is a Biotech company. It has raised $202M in total funding. Latest round: Series B.
Halda Therapeutics is a Biotech company. Halda Therapeutics has raised $202M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in August 2024. The round record for Halda Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Canaan Partners, Access Biotechnology, Connecticut Innovations, Elm Street Ventures, 6 Dimensions Capital, Access Industries. 6 distinct backers are named across the disclosed rounds.
We update the Halda Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026